Levels of microRNA-34a and hypoxic inducible factor-1α in type 2 diabetes patients with different urinary albumin excretion rates and their significance

HAN Xiuping; TAN Juan; HE Yumei

doi:10.7619/jcmp.20221742

Journal of Clinical Medicine in Practice > 2023 > 27(5): 114-118. > DOI: 10.7619/jcmp.20221742

HAN Xiuping, TAN Juan, HE Yumei. Levels of microRNA-34a and hypoxic inducible factor-1α in type 2 diabetes patients with different urinary albumin excretion rates and their significance[J]. Journal of Clinical Medicine in Practice, 2023, 27(5): 114-118. DOI: 10.7619/jcmp.20221742

Citation:

PDF (780 KB)

Levels of microRNA-34a and hypoxic inducible factor-1α in type 2 diabetes patients with different urinary albumin excretion rates and their significance

1.
Department of General Medicine, Affiliated Hospital of Yan'an University, Yan'an, Shaanxi, 716000
2.
Department of Traditional Chinese Medicine, Affiliated Hospital of Yan'an University, Yan'an, Shaanxi, 716000

More Information

Received Date: June 05, 2022
Revised Date: July 05, 2022
Available Online: April 06, 2023

Graphical Abstract

Abstract

Abstract

Objective
To analyze levels of microRNA-34a(miR-34a)and hypoxic inducible factor-1α (HIF-1α)in patients with type 2 diabetes(T2DM) with different urinary albumin excretion rates (AER) and their significance.
Methods
A total of 90 patients with T2DM were selected as T2DM group. At the same time, 90 healthy adults who underwent physical examinations in outpatient department during the same period were included in control group. According to different urinary AER, the patients in the T2DM group were divided into normal group, micro-amount group and large amount group, with 30 cases in each group. Serum HIF-1α level was detected by double antibody sandwich Enzyme Linked Immunosorbent Assay and the expression level of miR-34a in serum was detected by real-time fluorescence quantitative polymerase chain reaction. Blood glucose, serum HIF-1α, serum miR-34a level and AER level of each group were compared, and the correlations of AER level with serum miR-34a level and serum HIF-1α level in T2DM patients were analyzed, and the relationship between miR-34a and HIF-1α was analyzed. Receiver operating characteristic (ROC) curve was plotted, and the area under the curve (AUC) was calculated to evaluate the predictive value of HIF-1α and miR-34a for T2DM.
Results
Compared with the healthy group, the urinary albumin levels of the normal group, the micro-amount group and the large amount group were significantly higher, and their levels in the micro-amount group were higher than those of the normal group, and were higher in the large amount group than the micro-amount group(P < 0.05). Correlation analysis showed that AER level in T2DM patients was positively correlated with serum HIF-1α level and serum miR-34a level (r=0.75, 0.73, P < 0.05), and serum HIF-1α level was positively correlated with serum miR-34a level (r=0.55, P < 0.05). ROC curve showed that HIF-1α and miR-34a had high predictive value for T2DM, with AUC values of 0.991 and 0.934, respectively.
Conclusion
The higher the urinary albumin level in patients with T2D is, the more serious the disease will be. Serum HIF-1α level is positively correlated with serum miR-34a level, suggesting that miR-34a and HIF-1α are the influencing factors of T2DM disease and have high predictive value for T2DM.
- microRNA-34a,
- hypoxic inducible factor-1α,
- type 2 diabetes,
- urinary albumin excretion rate,
- urinary albumin

FullText(HTML)

References (18)

References

[1]	王莉华, 王怡, 彭超, 等. 2型糖尿病患者血糖控制前后肿瘤标志物变化及其影响因素[J]. 实用临床医药杂志, 2021, 25(5): 91-95. doi: 10.7619/jcmp.20200919
[2]	牛海芳. 早发2型糖尿病患者发病的危险因素及其在不同性别间的差异[J]. 广西医学, 2020, 42(14): 1804-1807, 1812. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYX202014012.htm
[3]	赵智伟, 张晓亚, 黄润之, 等. 2型糖尿病患者血脂水平与骨代谢的相关性研究[J]. 同济大学学报: 医学版, 2019, 40(4): 489-495, 500. https://www.cnki.com.cn/Article/CJFDTOTAL-TJIY201904018.htm
[4]	张乃莹, 黎波. 2型糖尿病相关血清生物标志物检测分析[J]. 实用临床医药杂志, 2020, 24(21): 79-81. doi: 10.7619/jcmp.202021023
[5]	温超, 谢元康, 陈懿建. miR-34a靶向调控HDAC1基因对急性髓系白血病细胞凋亡的影响[J]. 中国实验血液学杂志, 2019, 27(3): 790-795. https://www.cnki.com.cn/Article/CJFDTOTAL-XYSY201903028.htm
[6]	于佳龙, 黄南渠, 施尚鹏, 等. IDH1R132H、HIF-1α及VEGF在脑胶质瘤中的表达及与临床病理特征的关系[J]. 遵义医学院学报, 2018, 41(6): 716-721, 726. doi: 10.3969/j.issn.1000-2715.2018.06.012
[7]	仉慧颖, 耿威. 冠心病患者血清miR-34a和HIF-1α水平与冠状动脉侧支循环形成的相关性研究[J]. 重庆医学, 2019, 48(12): 2139-2141, 2155. doi: 10.3969/j.issn.1671-8348.2019.12.040
[8]	冯秀, 印滇, 王以浪, 等. 原发性肝细胞癌组织乏氧诱导因子-1α与MRP蛋白表达水平及病理诊断意义[J]. 中国中西医结合消化杂志, 2017, 25(6): 459-461, 465. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXPW201706017.htm
[9]	郝建兵, 唐杰, 郝丽荣. miR-34a/ATG4 B对db/db小鼠肾脏损伤中自噬和氧化应激的影响[J]. 医学综述, 2021, 27(16): 3298-3303. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZS202116032.htm
[10]	罗云霞, 余曦, 田敏, 等. 叔丁基对苯二酚(tBHQ)对2型糖尿病大鼠视网膜的长期保护作用[J]. 眼科新进展, 2021, 41(1): 32-36. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ202101007.htm
[11]	毛仁丽, 陈朝娟, 汪洪, 等. 血清补体C3、透明质酸及IL-6与2型糖尿病肾病的关系分析[J]. 标记免疫分析与临床, 2020, 27(8): 1337-1341, 1349. https://www.cnki.com.cn/Article/CJFDTOTAL-BJMY202008014.htm
[12]	魏丽芳, 吴彩娓, 波拉提·沙依提. 乳腺癌组织中原癌基因BMI-1及人表皮生长因子受体-2表达与外周血微转移的关系[J]. 中华实用诊断与治疗杂志, 2021, 35(1): 56-59. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202101014.htm
[13]	DENG M, ZHANG W, YUAN L, et al. HIF-1a regulates hypoxia-induced autophagy via translocation of ANKRD37 in colon cancer[J]. Exp Cell Res, 2020, 395(1): 112175.
[14]	ZUO H X, JIN Y, WANG Z, et al. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer[J]. J Ethnopharmacol, 2020, 257: 112835.
[15]	SAHA J, SARKAR D, PRAMANIK A, et al. PGE2-HIF1α reciprocal induction regulates migration, phenotypic alteration and immunosuppressive capacity of macrophages in tumor microenvironment[J]. Life Sci, 2020, 253: 117731.
[16]	WU L, XI Y L, KONG Q L. Dexmedetomidine protects PC12 cells from oxidative damage through regulation of miR-199a/HIF-1α[J]. Artif Cells Nanomed Biotechnol, 2020, 48(1): 506-514.
[17]	刘建林, 胡春艳, 李惠, 等. 基于KIM1/HIF-1α信号通路探讨糖尿病大鼠肾损伤的机制[J]. 中国中西医结合肾病杂志, 2020, 21(9): 786-788. https://www.cnki.com.cn/Article/CJFDTOTAL-JXSB202009015.htm
[18]	刘聪, 刘肃. miR-17-5p调控低氧诱导因子1α介导脂肪细胞分化及血管生成的分子机制[J]. 中国组织工程研究, 2021, 25(7): 1069-1074. https://www.cnki.com.cn/Article/CJFDTOTAL-XDKF202107018.htm

[1]	YIN Ying, GAO Yan, YANG Xiaoxin, MA Wenjing, WANG Wei. Application of family-involved nursing model under concept of rapid recovery in perioperative nursing for patients with pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2024, 28(11): 129-133. DOI: 10.7619/jcmp.20240679
[2]	LU Yanfeng, DAI Jiabao, WU Zhouquan, ZOU Zhiqing. Effect of esketamine on perioperative pain and depression in patients with thoracoscopic pulmonary nodule resection[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 90-94. DOI: 10.7619/jcmp.20234042
[3]	GAO Yan, WANG Wei, YANG Xiaoxin, DING Jiefang, YIN Ying. Precision nursing for patients with visualization technology assisted pulmonary nodule surgery[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 97-100, 106. DOI: 10.7619/jcmp.20233596
[4]	LIN Weiyong, WENG Wenjun. Identification characteristic of benign and malignant pulmonary nodules and differential diagnostic indicators of the infiltration degree of malignant ground-glass nodules[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 14-19. DOI: 10.7619/jcmp.20232071
[5]	WEI Xinqi, RUAN Aichao, YANG Ying, ZHANG Qing. Clinical nursing pathway management in patients with CT-guided thoracoscopic small pulmonary nodules resection[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 120-123. DOI: 10.7619/jcmp.20221144
[6]	LI Juanjuan, LIU Min, YANG Bin, DU Wei, YANG Hongkai, LIAO Yanquan, LI Junhang, WANG Jun. Application of artificial intelligence-assisted pulmonary nodule screening and qualitative diagnosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 8-12. DOI: 10.7619/jcmp.20214698
[7]	CAO Lan, TAO Yujian, ZHAO Yuanlu, ZHANG Pan. Analysis in risk factors of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 38-40, 44. DOI: 10.7619/jcmp.20200457
[8]	LIU Desen, CHEN Xiaochun, ZHU Feng, LIU Yongjie, CHEN Ming, LIU Feng, MA Haitao. Clinical analysis in chest CT and pathology of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2018, (7): 96-98. DOI: 10.7619/jcmp.201807026
[9]	ZHONG Chonghao, SHI Hongcan, SHU Yusheng, SHI Weiping, LU Shichun, SUN Chao. Establishment and clinical verification of a mathematical model foRpredicting the probability of malignancy oRbegin in patients with solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2017, (9): 82-85,93. DOI: 10.7619/jcmp.201709021
[10]	XI Xiaoxiang, LYU Bihong, YE Ting, HE Guangming, CHEN Rui, XU Xiang, WANG Baoguan. Value of serum NSE, Cyfra21-1, CEA and CA125 in diagnosis of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2015, (21): 41-43,51. DOI: 10.7619/jcmp.201521011

Cited By

Cited by

Periodical cited type(23)

1.	魏淑敏，陈岩，刘俊婷. 序贯肠内外营养支持辅助治疗急性脑卒中伴吞咽障碍临床观察. 社区医学杂志. 2024(02): 56-59 .
2.	王子雪. 两种营养护理方案在重症脑梗死患者中的应用. 中国城乡企业卫生. 2024(03): 102-105 .
3.	谢柏发，邓静，余刚. 早期肠内营养支持疗法在重症脑出血临床治疗中的效果及有效性分析. 基层医学论坛. 2024(10): 76-78+91 .
4.	吴苑云，范子英，卓月凤. 重症脑出血患者围术期营养支持的现状及研究进展. 现代医学与健康研究电子杂志. 2024(06): 128-131 .
5.	黄霞，张莉，狄红珍，冯小丹，朱梅. 早期序贯康复护理联合童趣化互动干预对外伤性颅内出血患儿的影响. 护理实践与研究. 2024(06): 821-827 .
6.	张明，刘逸文，文章. 早期肠内营养乳剂支持疗法治疗重症脑出血患者的临床研究. 广东药科大学学报. 2024(05): 127-131 .
7.	戴颖，龚丽. 重症脑出血患者应用ADOPT模式护理联合5A护理的效果. 医药前沿. 2024(15): 114-116 .
8.	郑蕾. 序贯式肠内营养支持对重症脑出血患者营养状况及胃肠道喂养不耐受的影响. 内蒙古医学杂志. 2023(02): 247-249 .
9.	黄玉琪，刘颖，石改红. ERAS理念指导的护理干预对前列腺增生患者术后康复的影响. 国际医药卫生导报. 2023(07): 1015-1020 .
10.	任丽敏. 营养支持联合早期运动整合干预对重症脑出血患者早期预后的影响. 中国实用乡村医生杂志. 2023(03): 59-63 .
11.	周琴，吴晓芳，王敏. 早期微生态肠内营养介入与管理在老年神经外科重症机械通气患者中的应用价值分析. 当代护士(中旬刊). 2023(05): 113-117 .
12.	刘艳红，葛利越，杨静，蒋大丽. 基于快速康复外科理念的分阶段护理干预联合序贯性EEN与康复锻炼对胃癌患者预后的影响. 海军医学杂志. 2023(06): 646-648 .
13.	李纲. 肠内营养序贯治疗对重症急性脑梗死合并吞咽功能障碍患者营养状态不良反应及并发症的影响. 中国药物与临床. 2022(02): 163-165 .
14.	赵轶梁. 早期肠内外营养联合支持在重症脑卒中患者中的应用效果观察. 实用中西医结合临床. 2022(01): 70-71+78 .
15.	崔益明，金守兵，陈彩霞. 早期肠内营养支持疗法在重症脑出血临床治疗中的效果. 吉林医学. 2022(04): 1044-1045 .
16.	贾亚杰，姚明. 肠内营养支持与肠外营养支持序贯治疗危重患者的临床价值. 中国医药科学. 2022(11): 187-189+196 .
17.	黄涵. 序贯性肠内营养在重症脑出血患者治疗中的应用效果分析. 中国社区医师. 2021(01): 20-21 .
18.	王德荣. 围手术期序贯性肠内营养在肝段切除患者中的应用及护理. 中外医学研究. 2021(15): 179-181 .
19.	王英华. 肠内营养支持结合个性化营养护理对原发性脑出血患者病情康复效果的影响. 中外医疗. 2021(21): 164-167+171 .
20.	汪海滔，陈伟鹏，邓惠森. 序贯性肠内营养在重症脑出血患者治疗中的应用效果分析. 吉林医学. 2021(10): 2476-2477 .
21.	杜欢，钱坤，姚淑芳. 序贯性早期肠内营养在重症脑出血患者中的应用效果. 中国民康医学. 2021(20): 39-41 .
22.	庞春. 术后早期应用肠内营养治疗重症脑出血患者术后腹泻的效果. 中国医药指南. 2020(31): 70-71 .
23.	冯二艳，罗书引，潘幸尧，郑红艳，丁宗励. 肠内序贯营养支持联合益生菌对重型颅脑损伤患者营养状况及胃肠功能障碍的改善作用研究. 解放军预防医学杂志. 2020(09): 127-130 .

Other cited types(0)

Get Citation

PDF

XML

Article views (171) PDF downloads (10) Cited by(23)

Turn off MathJax

Article Contents

Abstract

References

Levels of microRNA-34a and hypoxic inducible factor-1α in type 2 diabetes patients with different urinary albumin excretion rates and their significance